WallStreetZenWallStreetZen

NASDAQ: HSKA
Heska Corp Stock

$119.84-0.01 (-0.01%)
Updated Jun 2, 2023
HSKA Price
$119.84
Fair Value Price
$134.93
Market Cap
$1.31B
52 Week Low
$57.83
52 Week High
$119.90
P/E
-62.42x
P/B
3.13x
P/S
3.98x
PEG
N/A
Dividend Yield
N/A
Revenue
$254.89M
Earnings
-$20.03M
Gross Margin
42.9%
Operating Margin
-8.12%
Profit Margin
-7.9%
Debt to Equity
0.42
Operating Cash Flow
-$13M
Beta
1.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HSKA Overview

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HSKA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HSKA ($119.84) is undervalued by 11.18% relative to our estimate of its Fair Value price of $134.93 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HSKA ($119.84) is not significantly undervalued (11.18%) relative to our estimate of its Fair Value price of $134.93 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HSKA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HSKA due diligence checks available for Premium users.

Be the first to know about important HSKA news, forecast changes, insider trades & much more!

HSKA News

Valuation

HSKA fair value

Fair Value of HSKA stock based on Discounted Cash Flow (DCF)
Price
$119.84
Fair Value
$134.93
Undervalued by
11.18%
HSKA ($119.84) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSKA ($119.84) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSKA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HSKA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-62.42x
Industry
31.67x
Market
52.69x

HSKA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.13x
Industry
4.02x
HSKA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HSKA's financial health

Profit margin

Revenue
$62.4M
Net Income
-$10.1M
Profit Margin
-16.2%
HSKA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HSKA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$592.7M
Liabilities
$175.0M
Debt to equity
0.42
HSKA's short-term assets ($238.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSKA's short-term assets ($238.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSKA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HSKA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
-$22.6M
Financing
-$128.0k
HSKA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HSKA vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
HSKA$1.31B-0.01%-62.42x3.13x
FLGT$1.20B-0.91%-47.45x0.95x
NRC$1.12B+4.05%37.46x15.06x
OPK$1.12B+3.57%-3.72x0.72x
ME$945.57M+3.54%-2.97x1.32x

Heska Stock FAQ

What is Heska's quote symbol?

(NASDAQ: HSKA) Heska trades on the NASDAQ under the ticker symbol HSKA. Heska stock quotes can also be displayed as NASDAQ: HSKA.

If you're new to stock investing, here's how to buy Heska stock.

What is the 52 week high and low for Heska (NASDAQ: HSKA)?

(NASDAQ: HSKA) Heska's 52-week high was $119.90, and its 52-week low was $57.83. It is currently -0.05% from its 52-week high and 107.22% from its 52-week low.

How much is Heska stock worth today?

(NASDAQ: HSKA) Heska currently has 10,913,754 outstanding shares. With Heska stock trading at $119.84 per share, the total value of Heska stock (market capitalization) is $1.31B.

Heska stock was originally listed at a price of $123.80 in Dec 31, 1997. If you had invested in Heska stock at $123.80, your return over the last 25 years would have been -3.2%, for an annualized return of -0.13% (not including any dividends or dividend reinvestments).

How much is Heska's stock price per share?

(NASDAQ: HSKA) Heska stock price per share is $119.84 today (as of Jun 2, 2023).

What is Heska's Market Cap?

(NASDAQ: HSKA) Heska's market cap is $1.31B, as of Jun 5, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Heska's market cap is calculated by multiplying HSKA's current stock price of $119.84 by HSKA's total outstanding shares of 10,913,754.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.